Jennifer Tousignant
Consejero General en VIRIDIAN THERAPEUTICS, INC. .
Cargos activos de Jennifer Tousignant
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Consejero General | 15/02/2024 | - |
Historial de carrera de Jennifer Tousignant
Antiguos cargos conocidos de Jennifer Tousignant.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
XILIO THERAPEUTICS, INC. | Consejero General | 01/01/2020 | 01/11/2020 |
TESARO INC | Consejero General | 01/04/2016 | 01/10/2019 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
SANA BIOTECHNOLOGY, INC. | Consejero General | 01/09/2022 | - |
Formación de Jennifer Tousignant.
Suffolk University Law School | Graduate Degree |
University of Virginia | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
General Counsel | 4 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
SANA BIOTECHNOLOGY, INC. | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Tousignant
- Experiencia